Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

An international review demonstrates that GLP-1 weight-loss drugs such as Ozempic significantly reduce the risk of heart attacks, strokes, heart failure, and premature death. Researchers indicate these medications could serve as a major therapeutic tool against cardiovascular disease beyond their current use for obesity and diabetes treatment.